BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31961798)

  • 1. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood.
    Fujimoto M; Khoury JC; Khoury PR; Kalra B; Kumar A; Sluss P; Oxvig C; Hwa V; Dauber A
    Eur J Endocrinol; 2020 Mar; 182(3):363-374. PubMed ID: 31961798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pappalysins and Stanniocalcins and Their Relationship With the Peripheral IGF Axis in Newborns and During Development.
    Martín-Rivada Á; Guerra-Cantera S; Campillo-Calatayud A; Andrés-Esteban EM; Sánchez Holgado M; Martos-Moreno GÁ; Pozo J; Güemes M; Soriano-Guillén L; Pellicer A; Oxvig C; Frystyk J; Chowen JA; Barrios V; Argente J
    J Clin Endocrinol Metab; 2022 Sep; 107(10):2912-2924. PubMed ID: 35902207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in Pappalysin-2 Levels and Lower IGF-I Bioavailability in Female Adolescents With Anorexia Nervosa.
    Barrios V; Martín-Rivada Á; Guerra-Cantera S; Campillo-Calatayud A; Camarneiro RA; Graell M; Chowen JA; Argente J
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e920-e931. PubMed ID: 38066647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy associated plasma protein-A2 (PAPP-A2) and stanniocalcin-2 (STC2) but not PAPP-A are associated with circulating total IGF-1 in a human adult population.
    Nimptsch K; Aydin EE; Chavarria RFR; Janke J; Poy MN; Oxvig C; Steinbrecher A; Pischon T
    Sci Rep; 2024 Jan; 14(1):1770. PubMed ID: 38245583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.
    Fujimoto M; Hwa V; Dauber A
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):1-8. PubMed ID: 29280739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length.
    DiPrisco B; Kumar A; Kalra B; Savjani GV; Michael Z; Farr O; Papathanasiou AE; Christou H; Mantzoros C
    Metabolism; 2019 Nov; 100():153959. PubMed ID: 31401027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Changes in Serum IGF-I and Growth During Infancy: Associations to Body Fat, Target Height, and PAPPA2 Genotype.
    Upners EN; Ljubicic ML; Busch AS; Fischer MB; Almstrup K; Petersen JH; Jensen RB; Hagen CP; Juul A
    J Clin Endocrinol Metab; 2022 Jan; 107(1):219-229. PubMed ID: 34476481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low IGF-I Bioavailability Impairs Growth and Glucose Metabolism in a Mouse Model of Human PAPPA2 p.Ala1033Val Mutation.
    Fujimoto M; Andrew M; Liao L; Zhang D; Yildirim G; Sluss P; Kalra B; Kumar A; Yakar S; Hwa V; Dauber A
    Endocrinology; 2019 Jun; 160(6):1363-1376. PubMed ID: 30977789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability.
    Dauber A; Muñoz-Calvo MT; Barrios V; Domené HM; Kloverpris S; Serra-Juhé C; Desikan V; Pozo J; Muzumdar R; Martos-Moreno GÁ; Hawkins F; Jasper HG; Conover CA; Frystyk J; Yakar S; Hwa V; Chowen JA; Oxvig C; Rosenfeld RG; Pérez-Jurado LA; Argente J
    EMBO Mol Med; 2016 Apr; 8(4):363-74. PubMed ID: 26902202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does height and IGF-I determine pubertal timing in girls?
    Upners EN; Busch AS; Almstrup K; Petersen JH; Assens M; Main KM; Jensen RB; Juul A
    Pediatr Res; 2021 Jul; 90(1):176-183. PubMed ID: 33142306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein QTL analysis of IGF-I and its binding proteins provides insights into growth biology.
    Bartell E; Fujimoto M; Khoury JC; Khoury PR; Vedantam S; Astley CM; Hirschhorn JN; Dauber A
    Hum Mol Genet; 2020 Aug; 29(15):2625-2636. PubMed ID: 32484228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased IGFBP proteolysis, IGF-I bioavailability and pappalysin levels in children with Prader-Willi syndrome.
    Barrios V; Martín-Rivada Á; Martos-Moreno GÁ; Canelles S; Moreno-Macián F; De Mingo-Alemany C; Delvecchio M; Pajno R; Fintini D; Chowen JA; Argente J
    J Clin Endocrinol Metab; 2023 Dec; ():. PubMed ID: 38141219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders caused by genetic defects associated with GH-dependent genes: PAPPA2 defects.
    Fujimoto M; Andrew M; Dauber A
    Mol Cell Endocrinol; 2020 Dec; 518():110967. PubMed ID: 32739295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability.
    Yan X; Baxter RC; Firth SM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1412-20. PubMed ID: 20103653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult height and long-term outcomes after rhIGF-1 therapy in two patients with PAPP-A2 deficiency.
    Martín-Rivada Á; Barrios V; Martínez Díaz-Guerra G; Pozo J; Martos-Moreno GÁ; Argente J
    Growth Horm IGF Res; 2021; 60-61():101419. PubMed ID: 34358737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of Pappa2 gene may indirectly affect mouse hip development through the IGF signaling pathway.
    Chen Y; Li L; Wang E; Zhang L; Zhao Q
    Endocrine; 2019 Aug; 65(2):440-450. PubMed ID: 31168749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
    Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
    Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity.
    Christians JK; Bath AK; Amiri N
    Growth Horm IGF Res; 2015 Oct; 25(5):232-9. PubMed ID: 26164771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papp-a2 modulates development of cranial cartilage and angiogenesis in zebrafish embryos.
    Kjaer-Sorensen K; Engholm DH; Jepsen MR; Morch MG; Weyer K; Hefting LL; Skov LL; Laursen LS; Oxvig C
    J Cell Sci; 2014 Dec; 127(Pt 23):5027-37. PubMed ID: 25236600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.